Zhejiang Huahai Pharmaceutical Co Ltd (600521) — Financial Flexibility Index
Zhejiang Huahai Pharmaceutical Co Ltd (600521) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥697.36 Million (operating CF CN¥282.81 Million minus capex CN¥414.56 Million) represents 0% of total liabilities (CN¥11.55 Billion). Check strategic asset allocation of Zhejiang Huahai Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Huahai Pharmaceutical Co Ltd Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Zhejiang Huahai Pharmaceutical Co Ltd across 25 annual periods. See working capital to net assets of Zhejiang Huahai Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Huahai Pharmaceutical Co Ltd (2001–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Huahai Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Huahai Pharmaceutical Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.27x | CN¥3.20 Billion | CN¥1.23 Billion | CN¥12.05 Billion | ▼ -25.9% |
| 2024 | 0.36x | CN¥4.03 Billion | CN¥2.17 Billion | CN¥11.24 Billion | ▼ -2.7% |
| 2023 | 0.37x | CN¥3.81 Billion | CN¥2.22 Billion | CN¥10.35 Billion | ▲ +7.6% |
| 2022 | 0.34x | CN¥3.56 Billion | CN¥1.24 Billion | CN¥10.41 Billion | ▼ -11.9% |
| 2021 | 0.39x | CN¥3.37 Billion | CN¥938.43 Million | CN¥8.69 Billion | ▼ -14.1% |
| 2020 | 0.45x | CN¥2.83 Billion | CN¥1.56 Billion | CN¥6.27 Billion | ▼ -12.2% |
| 2019 | 0.51x | CN¥2.55 Billion | CN¥1.75 Billion | CN¥4.95 Billion | ▲ +165.9% |
| 2018 | 0.19x | CN¥1.19 Billion | CN¥67.90 Million | CN¥6.16 Billion | ▼ -53.6% |
| 2017 | 0.42x | CN¥1.34 Billion | CN¥546.24 Million | CN¥3.21 Billion | ▼ -23.1% |
| 2016 | 0.54x | CN¥1.17 Billion | CN¥433.10 Million | CN¥2.15 Billion | ▲ +35.4% |
| 2015 | 0.40x | CN¥719.59 Million | CN¥195.31 Million | CN¥1.80 Billion | ▼ -34.9% |
| 2014 | 0.62x | CN¥765.67 Million | CN¥328.61 Million | CN¥1.24 Billion | ▼ -6.9% |
| 2013 | 0.66x | CN¥956.53 Million | CN¥490.29 Million | CN¥1.45 Billion | ▲ +21.2% |
| 2012 | 0.55x | CN¥691.64 Million | CN¥243.83 Million | CN¥1.27 Billion | ▲ +5.1% |
| 2011 | 0.52x | CN¥543.58 Million | CN¥197.51 Million | CN¥1.05 Billion | ▼ -33.2% |
| 2010 | 0.78x | CN¥571.91 Million | CN¥299.47 Million | CN¥735.92 Million | ▼ -9.3% |
| 2009 | 0.86x | CN¥448.25 Million | CN¥317.44 Million | CN¥522.98 Million | ▲ +59.2% |
| 2008 | 0.54x | CN¥223.10 Million | CN¥84.20 Million | CN¥414.51 Million | ▼ -39.7% |
| 2007 | 0.89x | CN¥257.07 Million | CN¥136.52 Million | CN¥287.78 Million | ▼ -7.8% |
| 2006 | 0.97x | CN¥215.81 Million | CN¥77.54 Million | CN¥222.66 Million | ▼ -44.7% |
| 2005 | 1.75x | CN¥302.44 Million | CN¥53.30 Million | CN¥172.70 Million | ▼ -32.0% |
| 2004 | 2.57x | CN¥283.20 Million | CN¥163.73 Million | CN¥110.03 Million | ▲ +143.0% |
| 2003 | 1.06x | CN¥94.54 Million | CN¥47.41 Million | CN¥89.27 Million | ▲ +43.2% |
| 2002 | 0.74x | CN¥123.93 Million | CN¥75.34 Million | CN¥167.62 Million | ▲ +52.3% |
| 2001 | 0.49x | CN¥73.65 Million | CN¥37.51 Million | CN¥151.72 Million | — |